Creathor Venture expects its fourth and largest fund will allow the pan-European VC to invest in therapeutics companies previously considered too capital-intensive. Karlheinz Schmelig told BioCentury Creathor Venture IV, a mixed IT and life sciences...

Cevec Pharmaceuticals GmbH , Cologne, Germany Business: Supply/Service, Biomanufacturing Date completed: 2015-07-22 Type: Venture financing Raised: EUR4.5 million ($4.9 million) Investors: Investtodate; Peppermint VenturePartners; Creathor Venture; NRW.Bank; KfW; G.A.T. Holding; private investors; company management WIR Staff...

CAP-CMV GmbH , Cologne, Germany Business: Infectious Date completed: 3/24/14 Type: Venture financing Raised: €1.7 million ($2.3 million) Investors: Peppermint VenturePartners; NRW.Bank; Creathor Venture; KfW; private investors WIR Staff Infectious...

Cevec Pharmaceuticals GmbH , Cologne, Germany Business: Supply/Service, Biomanufacturing Date completed: 7/25/11 Type: Venture financing Raised: €6 million ($8.6 million) Investors: NRW.Bank; Creathor Venture; ERP Startfonds; existing investors; private investors; institutional investors WIR Staff...

Phenex Pharmaceuticals AG , Ludwigshafen, Germany Business: Metabolic, Endocrine, Cancer Date completed: 9/21/10 Type: Venture financing Raised: $7.9 million Investors: Creathor Venture; EVP Capital; LBBW Venture Capital; CD-Venture GmbH; Swiss Life; KfW; private investors WIR Staff...

caprotec bioanalytics GmbH , Berlin, Germany Business: Proteomics, Supply/Service Date completed: 5/13/10 Type: Venture financing Raised: €4 million ($4.9 million) Investors: Creathor Venture; IBB Beteiligungsgesellschaft; ERP Startfonds; private investors WIR Staff...

Cevec Pharmaceuticals GmbH , Cologne, Germany Business: Supply/Service, Biomanufacturing Date completed: 11/3/09 Type: Venture financing Raised: €4 million ($5.9 million) Investors: Creathor Venture; NRW.Bank; Sparkasse KoelnBonn; ERP Startfonds; private investors WIR Staff...